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1. Introductory Comments  
Reforming the Romanian healthcare system has never been proven to be an easy 
task, especially in terms of pertinent legislation, medical mobility or financial 
sustainability and the episodic attempts, such as the adoption of Law 95/2006 on 
reformative measures in the field of public health, later modified, merely 
represented modest steps for the Romanian Public Administration. On the other 
side of the coin, the relative urgency of the healthcare reform, after EU’s 
enlargement in 2007 by accepting Romania and Bulgaria, is currently doubled by 
the provocation launched for the two new Member-states in terms of 
approximation of legislation in the field of consumers of medical services’ rights, 
under the frame of the European Union’s law. Recently, the urgency of political 
decision and legislative innovation became more salient by the adoption, on 7 July 
2010, of Directive 2010/45/EU of the European Parliament and of the Council on 
standards of quality and safety of human organs intended for transplantation1, 
raising for the Romanian legal system the question of rapidly adapting its 
regulation and procedures to the newly introduced European standards. 
At the EU’s level, adopting Directive 2010/45/EU of the European Parliament and 
of the Council on standards of quality and safety of human organs intended for 
transplantation indubitably marks an important progress toward uniform high 
standards of security in the mentioned area, while representing a provocation for 
the Member States to modernize and harmonize national criteria of safety in the 
field of organ transplants. The new European regulation brings a series of major 
changes referring to the collecting of organs procedure, donor’s informed consent 
and transport of human organs. For instance, the reporting system and management 
concerning serious adverse events and reactions associated to the human organs 
transplant are reformed, as to ensure common standards, applicable in all Member 
States, along with a uniform procedure of organ traceability. Essential in the 
economy of human organs transplants becomes the “characterization of donor’s” 
procedure, seen as a preparatory stage, before transplantation, in which trained 
medical personnel collects relevant data on the donor, respecting the two 
informational settings offered in Annex A and B of the Directive discussed, 
containing sets of essential minimum data, collected for each donation and of  
complementary data to be collected in addition, based on the decision of the 
                                                 
1
 Directive 2010/45/EU has been published in the Official Journal of the European Union L 207/14 




medical team, taking into account the availability of such information and the 
particular circumstances of the case.  
Offering human organs for transplantation keeps its non profit character under the 
regulation of article 13 of Directive 2010/45/EU, banning national legal provisions 
which are indulgent to offers of organs purchase and imposing to all Member 
States the adoption of regulations forbidding the sell of organs; the only licit 
variant remains that of non payable offers, through the judicial means of living or 
deceased donations. An annual report, publicly accessible, on competent national 
authorities’ activities related to the testing, characterization, procurement, 
preservation, transport and transplantation of organs intended for transplantation 
into the human body becomes compulsory, under the terms of article 18 of the 
Directive, as observed in the lines below.  
The time factor may also constitute a source of worries, as the Romanian legislator 
is expected to transpose Directive 2010/45/EU before 27 August 2013 and report to 
the European Commission and every three years thereafter, on the activities 
undertaken in relation to the provisions of the Directive in discussion and on the 
experience gained in implementing it, which leaves Romanian Administrative 
authorities a two years period for complying to the European requirements, by 
adopting an adequate set of legal measures on organs donations and supervising 
their transposition into practice.  
Romania’s compliance to the new European regulations may be expected to 
represent a significant progress, in comparison to the ambiguous legislation in 
force, namely Law 95/2006 on reformative measures in the field of public health 
(later modified) and the introduction by the Public Administration of resort of the 
new European standards of quality and safety for the human organs transplant 
procedures is more than salutary, though it does not constitute an easy task.  
Administrative measures to be taken will imply: (a) creating a specialized 
Administrative body, uncharged with the accurate, rapid and verifiable reporting 
(to the European organisms inclusively) of serious adverse events and reactions 
related to human organs transplants; (b) creating national and local Administrative 
organs in charge of the management of serious adverse events and reactions in 
accordance with Directive 2010/45/EU provisions; (c) elaboration of new 
legislation on packaging and labeling of organs in accordance with the new 
European standards, as the actual Romanian legislation in force lacks explicit 
imperative provisions on standards regarding human organs packaging and 
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labeling; (d) elaboration of legal rules and specific Administrative procedures for 
the authorization of transplantation centers; (e) the establishment of conditions of 
procurement and systems of traceability of organs intended for transplantation into 
the human body etc.  
The article therefore analyses the implications of the most recent European 
regulations in the field of Administrative procedures related to human organs 
transplant – Directive 2010/45/EU of the European Parliament and of the Council 
on standards of quality and safety of human organs intended for transplantation – 
on national medical and legal procedures related to numerous aspects such as 
donation, testing, characterization, procurement, preservation, transport and 
transplantation of organs intended for transplantation into the human body, 
obviously excluding the cases when such organs are used exclusively for research 
purposes. Directive 2010/45/EU provisions are also expected to have an important 
impact on Romanian legal texts, as removing disparities on donor’s consent 
procedure or on standards of safety related to the transport of human organs, for 
example, become necessary. This paper also attempts to offer an overview of the 
essential aspects thought to characterize the new European framework for quality 
and safety in the field of transplantation of human organs, as set by Directive 
2010/45/EU, referring to the Administrative procedures of verification of donor’s 
identity; the verification of donor's / donor's family's consent; the verification of the 
completion of the organ and donor’s characterization; the procurement, 
preservation, packaging and labeling of organs in accordance with the new 
European standards set by Directive 2010/45/EU provisions; the transportation of 
organs in accordance with the harmonized European rules; ensuring traceability of 
human organs, guaranteeing compliance with the European Union’s and national 
provisions on the protection of personal data and confidentiality; the accurate, rapid 
and verifiable reporting of serious adverse events and reactions; the management of 
serious adverse events and reactions in accordance with Directive 2010/45/EU 
provisions.  
Also, it should be observed that the new EU’s legislation is meant to ensure that 
organs comply with recognized standards of quality and safety, despite the initial 
discrepancies in national regulations and that the later will be finally harmonized, 
as to reassure consumers of medical services that human organs “procured in 




obtained in their own country”1. The necessity of establishing common quality and 
safety standards for the procurement, transport and use of organs at the European 
Union’s level, in the context in which these common standards would facilitate 
exchanges of organs to the benefit of an enormous group of European patients in 
need of this type of therapy each year, justified the recent developments of the 
European Law, as synthesized in Directive 2010/45/EU provisions. It should be 
added that Directive 2010/45/EU, although having as its first objective the safety 
and quality of organs, indirectly contributes to combating organ trafficking through 
the establishment of competent authorities, the authorization of transplantation 
centers, the establishment of conditions of procurement and systems of traceability, 
as unacceptable practices in organ donation and transplantation – including 
trafficking in organs, sometimes linked to trafficking in persons for the purpose of 
the removal of organs – also constitute a serious violation of EU citizens’ 
fundamental rights and, in particular, of human dignity and physical integrity.  
 
2. Theoretical Background 
Liability of Public Administration for damages caused by unsafe transplant 
procedures represents one of the major themes, in the recent specialized literature2. 
For instance, one stream of research found that no difference of treatment, when 
establishing the existence of the culpability, is to be made between private clinics 
and public hospitals, as both are compelled to respect safety standards associated to 
medical services (Mangu, 2010) (Turcu, 2010, p. 237). A second body of literature, 
which focused on general paradigms of responsibility related to contracts 
concluded by consumers of medical services, found that risks of unsafe products 
and procedures are, in practice, frequently associated with the use of human organs 
in transplantation and that use of uniform, well organized national and international 
transplantation systems can significantly reduce the associated risks of transplanted 
organs for recipients3. A third group of studies investigated the effects of 
exoneration clauses over public hospitals’ liability, arguing that the gravity of 
                                                 
1
 As underlined in the sixth paragraph of Directive 2010/45/EU Preamble.  
2
 See, for further details (Astărăstoae, 2010, p. 23; Borzan & Mocean, 2002, pp. 89-112; Fauvarque-
Cosson, 2007, pp. 956-960; Guettier, 1996, pp. 226-227; Turner, 2011, p. 23; 1-7) 
3
 For a fully analysis of the issue (Simion, 2011, passim). For other European experiences in the field, 
see for instance (Grytten & Sørensen, 2009, pp. 11–27) 
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damages is not to be superposed on the concept of medical fault (Waline, 2010, p. 
184)1. 
While previous research has attempted to determine whether the concept of 
medical fault should play a role in determining public hospitals’ liability for 
damages caused in the field of organs transplant or whether a objective type of 
liability should be imposed, independent of the victim’s success in proving a 
medical fault, but dependent on the clinic’s failure to prove its lack of negligence, 
the extent to which such criteria are to be used in determining public hospitals’ 
responsibility for traceability of negative reactions and events related to human 
organs transplant remains unknown. This is an important gap in the literature 
because, realistically, these criteria do not operate in isolation. Indeed, a prominent 
theory of civil liability, le Tourneau’s (2000) social policies theory (le Tourneau & 
Cadiet, 2000)2, states that establishing a national compensation fund destined to 
cover financial losses of medical malpraxis victims in the public health system, 
including the field of organs transplants, becomes vital in the XXI century society, 
extracting victims from the insurmountable situation when the responsible public 
hospital does not dispose of financial resources as to cover damages caused and 
established by a legal sentence. Unfortunately, Romanian literature lack debates on 
the establishment of such national compensation fund, as well as on the sources to 
be used for contributions (for instance, a percentage of the monthly contribution to 
medical and social insurance funds).  
The lack of specialized literature allocated to the theme of Administrative 
procedures of consent to organ donation and traceability of transplants, on the other 
side of the coin, is explained by the fact that the change of the European standards 
of quality and safety is very recent, as the adoption of Directive 2010/45/EU 
operated on 7 July 2010. Nevertheless, Romania, as well as the other Member 
States is expected to designate, until 2013, one or more competent authorities of 
the Public Administration in the area concerned with Directive 2010/45/EU 
provisions (probably subordinated to the Health Department)3. Secondly, after its 
designation, the competent national authority is called to establish and keep 
                                                 
1
 For further details see (Tapinos, 2008, p. 311) as well as, for Romanian literature (Popa, 2003, pp. 
59-63; Frunză, 2009, pp. 3-23). 
2
 For an interesting insight, see (Shah, Brieger & Peters, 2011, pp. 275-287). 
3
 To this respect, Member States are allowed to delegate (or may allow a competent authority to 
delegate) part or all of the tasks assigned to it under Directive 2010/45/EU to another body which is 





updated a framework for quality and safety in accordance with article 4 of 
Directive 2010/45/EU. In addition, organ procurement organizations and 
transplantations centers will have to be controlled or audited on a regular basis, to 
ascertain compliance with the requirements of the Directive.  
Donor’s consent to the transplant procedure, in the field of living donations, as well 
as in the perimeter of deceased donations, also raises the question of the legal right 
to retract his / her prior consent on the basis of the information received on the 
consequences and the risks of the medical procedure involved, as donor’s consent 
needs to be based on a free, informed and unequivocal manifestation of will.  A 
general theory of the consent retract in the Romanian Consumer Law is generally 
absent, both the judicial doctrine and the juridical practice being not familiarized 
with the problematic of the mentioned judicial concept, thus the necessity of 
harmonizing national regulations with the new European legal provisions becomes 
urgent, as the text of Law 95/2006 on reformative measures in the field of public 
health, later modified, does not include a specific procedure for donor’s withdrawal 
of prior consent. The sole internal approach of the theme consisted in salutary 
analyses, unfortunately punctual and incomplete, based on the investigation of 
classical species of withdrawal rights. Similarly, the rare references made to the 
subject of the patients’ right to retract their assent on the bases of the insufficiency 
of information delivered kept unsolved legal problems as the progressive formation 
of consent to a medical act. In the field of Romanian law, analyzes of the 
consumers legal right of consent withdrawal are sporadic, the major characteristics 
of retract rights reserved by convention remaining unexplored and unexploited.  
 
3. Practical Difficulties Associated to the Harmonization of the Organ 
Procurement Procedures 
One of the most salient tasks of the Romanian authorities in the next two years is to 
grant, suspend or withdraw, as appropriate, the authorizations of procurement 
organizations or transplantation centers or prohibit procurement organizations or 
transplantation centers from carrying out their activities, where control measures 
demonstrate that such organizations or centers are not complying with the 
requirements of the Directive; on the other versant, a reporting system and 
management procedure for serious adverse events and reactions is expected to be 
put in place at the Romanian healthcare system’s level, as provided for in article 
11, paragraph (1) and (2) of the Directive. Widening especially the traditional 
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Romanian point of view, the Heath Department is expected to issue appropriate 
guidance to healthcare establishments, professionals and other parties involved in 
all stages of the chain from donation to transplantation or disposal, which may 
include guidance for the collection of relevant post-transplantation information to 
evaluate the quality and safety of the organs transplanted; it is well known that, at 
the moment, no uniform guides and procedures are used, on the Romanian 
territory, for legal organ procurement and pre and post transplantation storage of 
information.  
Finally, protection of collected personal data regarding donors and recipients 
constitutes another important feature of the harmonized system proposed in the text 
of Directive 2010/45/EU, Romanian authorities being also called to ensure that the 
fundamental right to protection of personal data is fully and effectively protected in 
all organ transplantation activities, in conformity with EU’s provisions on the 
protection of personal data, in particular Directive 95/46/EC; in addition, 
competent authorities are called to participate, whenever possible, in the European 
network of competent authorities referred to in article 19, to coordinate at national 
level input to the activities of that network and to supervise organ exchange with 
other Member States and with third countries as provided for in article 20, 
paragraph (1) of the Directive.  
Focusing on the records and reports concerning procurement organizations and 
transplantation centers, it should be noted that article 18 of the mentioned directive 
imposes Member States to ensure that the competent authority: (1) registries the 
activities of transplantation centers and procurement organizations, the numbers of 
living and deceased donors and the types and quantities of organs procured and 
transplanted included and that the activity of data registration respects the EU’s and 
national provisions on the protection of personal data and those concerning the 
statistical confidentiality; (2) an annual report on the activity of the national 
competent authority in the field of organ transplantation is elaborated and made 
publicly accessible; (3) an updated record of procurement organizations and 
transplantation centers is established and maintained at a national level. In this 
context, all Member States are compelled to provide information on the record of 
procurement organizations and transplantation centers, upon the request of the 
European Commission or of another Member State, as to ensure the accessibility of 
this information at the EU’s level. The public character of this annual report is also 




beneficiaries of the centralized informational system described in the Directive 
2010/45/EU text.  
None of these administrative bodies exist, at the moment, in the autochthon 
healthcare system; both reporting and recording procedures are expected to become 
available in the next two years, by the effort of the Health Department. Exchange 
of information at the EU’s level, on all the relevant aspect associated to the human 
organs transplants is not to be neglected and according to the Directive provisions, 
the European Commission will organize a network of the national competent 
authorities concerning the exchange of information on their experience acquired as 
regarding the implementation of the Directive; consequently, in certain cases, 
experts on organ transplantation, data protection supervisory authorities or 
representatives from European organ exchange organizations, as well as other 
relevant parties will have the capacity of associating with the mentioned network 
(article 19 of Directive 2010/45/EU on standards of quality and safety of human 
organs intended for transplantation). 
Reports concerning the application of the Directive by each Member State are 
regulated by article 22, imposing that Member States report to the European 
Commission before 27 August 2013 and every three years thereafter on the 
activities undertaken concerning the application of Directive provisions and on the 
experience gained by the national authorities in implementing the common 
European standards of quality and safety. In addition, before 27 August 2014 and 
every three years thereafter, the European Commission will transmit to the 
European Parliament, the Council, the European Economic and Social Committee 
and the Committee of the Regions, a report on the implementation of the Directive. 
As to the penalties applicable to non compliance to the new European standards of 
quality and safety of human organs intended for transplantation, it is the Member 
States mission to establish specific rules on penalties applicable to infringements of 
the national provisions adopted while transposing the Directive into internal law 
and thus to take all measures necessary to ensure that the prescribed penalties are 
thoroughly implemented. Directive’s authors mentioned, however, in article 23, 
that the penalties provided for must be “effective, proportionate and dissuasive”.  
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4. Procedures of Consent to Organ Donations: Opting-in versus Opting-
out Systems 
Removing obsolete procedures in the field of consent to organ donation represents 
one of the most important tasks of Romanian Public Administration in the next two 
years. Inspiration for the new model of consent may be found in several models of 
consent to donation that coexist in the Union, including opting-in systems, in which 
consent to organ donation has to be explicitly obtained (a) and opting-out systems, 
in which donation can take place unless there is evidence of any objection to 
donation (b). Certain Member States have even developed specific registries 
systems, in which citizens interested in consenting to an organ donation record 
their prior assent; such official records constitute, in our opinion, one of the zones 
where the import of legislation is necessary. On one hand, is should be noted that 
Directive 2010/45/EU is not intended to prejudice the broad diversity of the 
systems of consent already in place in the Member States, but to ensure that 
harmonized forms of informed consent become available at the EU’s level. On the 
other hand, however, it should be recalled the interminable hesitancies that have 
been accompanied Romanian legislator’s attempts, in 2006, when adopting Law 
95/2006 on reformative measures in the field of public health (later modified), of 
reforming medical procedures of consent. In fact, there is no uniform procedure or 
harmonized forms to be respected by the Romanian public hospitals regarding 
patient’s assent to organ donations and transplants, each hospital usually using its 
own types of document and thus the discrepancies between medical practices being 
frequent (Simion, 2011, p. 311; Turcu, 2010, p. 216). 
It is largely known that the consent to a medical procedure involving transplant of a 
human organ may be emitted also by the donor’s family, in cases mentioned by 
national regulations, usually implying donor’s impossibility, at the time of the 
medical act, to express his / her will regarding the transplant procedure; in certain 
national legislations, however, the validity of donor’s family consent is conditioned 
by the inexistence of donor’s living refuse of the transplant, expressed while being 
alive. However, an attentive analyze of Law no. 95/2006 on reformative measures 
in the field of public health provisions shows that the Romanian legislator avoided 
the establishment of a univocal setting in the field of donor’s consent, the opting-in 
system coexisting with the opting-out system, as the patient is allowed to either 
express his or her refusal to donate while alive, either to expressly consent to an 
organ donation, regulating that donation can take place unless there is evidence of 




Import of European recognized principles guiding practices in organ donation and 
transplantation becomes urgent, including the certification or the confirmation of 
death in accordance with national provisions before the procurement of organs 
from deceased persons and the allocation of organs based on transparent, non-
discriminatory and scientific criteria. Therefore, it is Health Department’s task to 
elaborate in the next two years uniform national forms for the certification or the 
confirmation of death (a), in the case of donors, a transparent (probably electronic) 
data basis of allocation of organs and recipients’ identity (b), along with 
harmonized forms of donor’s and recipient’s consent to an organ transplant1 (c).  
As mentioned above, the organ characterization also falls under the sphere of 
incidence of Directive 2010/45/EU, referring to the collection of all the “relevant 
information on the characteristics of the organ, needed to evaluate its suitability, in 
order to undertake a proper risk assessment, to minimize the risks for the recipient 
and optimize organ allocation” (article 3). While the procurement of human organs 
describes the process by which the donated organs become available for the 
potential recipients, the activity of organs preservation means “the use of chemical 
agents, alterations in environmental conditions or other means to prevent or retard 
biological or physical deterioration of organs from procurement to 
transplantation”. Finally, by procurement organization it should be understood “a 
healthcare establishment, a team or a unit of a hospital, a person, or any other 
body which undertakes or coordinates the procurement of organs, that is 
authorized to do so by the competent authority under the regulatory framework in 
the Member State concerned”, as regulated by article 3 of Directive 2010/45/EU.  
The transplantation of organs process, as defined by the cited article 3, refers to a 
the medical procedure intended to restore certain functions of the human body by 
transferring an organ from a donor to a recipient; from the angle of the applicability 
of  Directive 2010/45/EU into national law, traceability of human organs destined 
to be transplanted is also important, as referring to the ability to locate and identify 
                                                 
1As indicated in article 2, Directive 2010/45/EU is applicable to donation, testing, characterization, 
procurement, preservation, transport and transplantation of organs intended for transplantation into 
the human body, excluding in principle the cases when such organs are used exclusively for research 
purposes. In this context, the “human organ” is legally defined as “a differentiated part of the human 
body, formed by different tissues, that maintains its structure, vascular capacity and capacity to 
develop physiological functions with a significant level of autonomy”; on the other hand, a part of an 
organ is also considered to be an organ, to the purpose of the application of Directive 2010/45/EU 
provisions, “if its function is to be used for the same purpose as the entire organ in the human body”, 
maintaining the requirements of structure and vascular capacity (article 3 of Directive 2010/45/EU). 
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the organ at each stage in the chain from donation to transplantation or to organ 
disposal, in cases in which the transplant is canceled on subjective or objective 
criteria, including the ability to identify the organ donor, as well as the 
procurement organization, respectively to identify the recipient(s) at the 
transplantation centre(s) and, finally, to locate and identify all relevant data, 
constituting non-personal information and concerning products and materials 
which came into contact with that human organ intended for transplantation. In this 
context, is should be underlined the vital intervention of the transplantation centers, 
defined as healthcare establishments, teams or units of a hospital or any other 
bodies which undertake the transplantation of organs and are authorized to this 
respect by the national competent authority in each Member State, under a specific 
regulatory framework, developed into national law in order to establish standards 
for the transplantation centers’ functioning.  
A few considerations are reserved for the Romanian authorities’ option for the 
consecration of both living and deceased donations. The latter is practiced along 
with the former in most European medical systems, as living donation coexists 
with deceased donation in almost all Member States, the judicial difference being 
extracted from the formal declaration of will; in the first case, the donor accepts 
that the transplant take place during his/her life, while in the second case, the 
consent becomes effective after donor’s death. As mentioned in Directive 
2010/45/EU preamble, the evolution of living donation over the years permit 
extracting the conclusion that good results can be obtained even where there is no 
genetic relationship between donor and recipient, grace to recent developments of 
medical science; however, risk of disease transmission could jeopardize the success 
of the transplant procedure.  
Therefore, living donors should be subject to an adequately elaborated procedure of 
evaluation, meant to determine their suitability for donation and also to minimize 
the risk of disease transmission to the organ recipients, a field in which the 
necessity on uniform European standards of safety becomes evident1. Regarding 
                                                 
1
 In addition, living donors face risks linked both to testing to ascertain their suitability as a donor and 
to the procedure to obtain the organ. In this field, medical, surgical, social, financial or psychological 
complications may arise, while the level of risk depends, in particular, on the type of organ to be 
donated, as well as on the type of medical procedure involved. Therefore, living donations need to be 
performed in accordance with uniform European standards, which are applicable in each Member 
State, in a manner that minimizes the physical, psychological and social risk to the individual donor 
and to the recipient, while the public's trust in the healthcare community is maintained. See (Frunză, 




donor’s consent, it should be underlined that the potential living donor has to be 
able to take an independent decision on the basis of all the relevant information 
concerning the organ procurement, as well as the consequences and dangers of the 
medical procedures attached and the associated risks, while properly and priory 
informed on the purpose and nature of the donation.  Legal questions related to the 
organization of health care services providing transplant services and doctor patient 
relationship while discussing potential organ donations are addressed by numerous 
provisions of Directive 2010/45/EU, which are meant to guarantee respect of 
common principles governing donation of human organs and to ensure the highest 
possible standard of protection for the living donors, both in the judicial and the 
medical area. It should also be noted that some Member States are signatories to 
the Convention on Human Rights and Biomedicine of the Council of Europe, and 
its additional protocol on Transplantation of Organs and Tissues of Human Origin, 
the provisions of which become incident also in the field of human organs 
transplant, when appropriate. Therefore, a proper evaluation of potential donors, a 
complete and thorough information on the essential data concerning the transplant 
and an adequate follow-up of transplant successes, in the process of organ 
traceability, are internationally recognized measures aimed at protecting the living 
donors, as well as the organ recipients, measures also contributing to quality and 
safety of organs insurance, in the absence of which complications may be medical, 
surgical, social, financial or psychological.  
Another aspect relies to the efforts to be made as to increase deceased organ 
donation, which as opposed to living donation, represents no risk to the donor, 
concerning medical complications or death arising from the transplant procedure. 
In this context, it is important to stretch the necessity of legal procedures of consent 
to organ donation in the case of decedent’s family members, as in practice the rate 
of family refusals to consent to organ donation remains high. Posterior to patient’s 
death, it is the difficulty of dealing with a great emotional distress and suffering 
that makes families’ decision-making concerning organ donations much more 
difficult that for a living donor, as families tend to concentrate their attention on 
aspects such as the circumstances in which the diagnosis of death is made and on 
the protection of the decedent’s bodily integrity. Thus Member States efforts have 
to be focused on educational programs towards families’ consenting to deceased 
organ donation, underlining their importance in the process of life-saving for 
otherwise incurable patients.  
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The salient negative aspect, on the other hand, is the lack of regulation in the field 
of patients’ rights of withdrawal of life-sustaining treatment, a problem commonly 
associated to the transplant of human organs and unfortunately kept outside the 
incidence of Directive 2010/45/EU, whose authors chose not to elaborate on 
procedures related to the mentioned withdrawal. Patients whose existence is 
severely limited and dependent on some form of life-sustaining treatment, such as a 
ventilator or feeding tube raise the question of knowing if having these treatments 
withdrawn is or not to be seen as a question of a legal right of retract, permitting 
them to avoid a persistent vegetative state and allowing human organs to be 
procured for transplant purposes.  
The major legal problem associated to withdrawal of life-sustaining treatment, 
unfortunately unsolved by Directive 2010/45/EU, nor by Romanian legal 
provisions, is the lack of clear and convincing standards to be used by courts in 
order to determine the adequacy of an individual’s expressed will not to be 
maintained by life-supporting measures, while consenting to an organ transplant. 
As to the free character of donor’s will, is has been reaffirmed that patient’s right to 
self-determination remains crucial in the context of informed consent. The concept 
of patient’s right to the preservation of his/her bodily integrity lies under the 
national regulations, being not described in the Directive 2010/45/EU text; 
however, due to its firm constitutional foundation, the mentioned right is usually 
guaranteed by the means of national regulations.  
Similarly, the recipient’s consent has to present the same free character as the 
donor’s, the potential recipient having the right to refuse invasive treatment or have 
withdrawn various life-saving or life-sustaining therapies, as part of patient’s right 
to self-determination. Generally, legal discourse has given considerable difference 
to a patient’s right to refuse treatment, including an organ transfer, whether the 
potential recipient of the human organ was competent and legally able to make his 
or her whishes known (a) or mentally incompetent or speaking through a surrogate 
(b), in which case no valid consent was expressed. Patient’s legal competency 
usually raises no difficulty, as the patient is able to assert his or her rights 
individually; however, is has been held that a patient’s decision to have vital 




does not constitute proof of legal incompetence and therefore represents an 
unequivocal manifestation of will1.   
 
5. Adapting Healthcare Policies to the New European Standards  
As observed above, Romanian healthcare authorities are called to adapt medical 
procedures of organ transplantation to the new European quality and safety 
standards before 2013. Article 15 of Directive 2010/45/EU reminds Member States 
that they are compelled to adopt appropriate measures meant to ensure the highest 
possible protection of living donors in the process of organ procurement and 
transplant, while guaranteeing the quality and safety of organs intended for 
transplantation; in particular, selection of living donors has to be performed on the 
basis of donors’ health and medical history, while the competent healthcare 
professionals are suitably qualified and trained, with respect to the European 
standards of quality in the field of organ transplantation. Taken as a whole, the 
mentioned assessments may provide for the exclusion of persons whose donation 
could present unacceptable health risks for the organ recipients. In addition, 
Member States will organize a national register or record of the living donors, 
which is kept in accordance with the European Union’s and national provisions on 
the protection of the personal data and statistical confidentiality. Therefore, as a EU 
member, Romania shall pursuit the establishing of a follow-up of living donors 
system and shall organize a system meant to identify, report and manage any event 
potentially relating to the quality and safety of the donated organ, also focused on 
the recipient’s safety, while registering all serious adverse reactions that may result 
from the donation for the living donor, as well as for the organ recipient. These 
standards present patients with more effective access to high-quality medical care 
concerning the transplantation steps and is, therefore, an important legal tool in 
strengthening patients’ rights. 
  
                                                 
1In the terminology coined by (Turcu, 2010, p. 288) the donor has the right to be adequately informed 
on the entire medical and judicial consequences of his / her will, the accent being put, while 
discussing the judicial content of the duty of information, on the purpose and nature of the donation, 
its consequences and its risks, as essential pillars of donor’s will. 
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5.1. National Register of Living Donors 
Creating a national record system of the living donors is of crucial importance to 
the development of Romanian uniform system of organs traceability. When 
transposing in the national law Directive 2010/45/EU provisions, Member States 
are called to ensure that all procured organs and the donors thereof are 
characterized or are subjected to a “characterization procedure” before 
transplantation, implying the collection of the relevant information set out in the 
Annex of the Directive. These informative documents contain a set of minimum 
data which has to be collected for each organ donation, prior to the transplant 
procedure, while information specified in Part B of the Annex contains a set of 
complementary data to be additionally collected upon the decision of the medical 
team, adapted to the availability of such information on the organ donor and 
recipient and to the particularities of the transplant case. The use of the risk-utility 
balance as a criterion is expressly favored in the text of article 7 of Directive 
2010/45/EU, establishing that, if according to a risk-benefit analysis in a particular 
case, including in life-threatening emergencies, the expected benefits for the 
recipient outweigh the risks posed by incomplete data, an organ may be considered 
for transplantation even where not all of the minimum data specified in Part A of 
the annex are available. The “donor characterization” procedure, as set by article 7 
of the Directive, implies the collection of relevant information on the 
characteristics of the organ donor, needed to evaluate his/her suitability for organ 
donation, in order to undertake a proper risk assessment and minimize the risks for 
the recipient, as well as optimize organ allocation. As usually noted, at the moment 
the Romanian medical system does not use a standardized donor characterization 
procedure, the implementing of the new European standards thus representing an 
absolute novelty for the autochthon Public healthcare system.    
 
5.2. National Data Bases on Serious Adverse Events  
One of the most important branches of the Public healthcare authorities’ duty 
becomes the establishing of national data bases on serious adverse events, referring 
to the registration of all undesired and unexpected occurrences associated with any 
stage of the transplantation chain, from donation to effective transplant, that might 
lead to the transmission of a communicable disease, to death or life-threatening, 
disabling or incapacitating conditions for patients or which results in, or prolongs 




making complaints and are guaranteed remedies and judicial compensation in 
hypotheses of harm caused by the treatment received associated to a transplant 
procedure. 
The serious adverse reactions, on the other hand, are defined as unintended 
responses, including a communicable disease, in the living donor’s health state or 
in the recipient’s, that might be associated with any stage of the transplant chain, 
from organ donation or procurement to transplantation, response that is fatal, life-
threatening or disabling, even incapacitating for the recipient or for the living 
donor; in this category are also included medical responses to an organ transplant 
that result in or prolong patient’s hospitalization or morbidity, upon the case; 
relevant data on these negative responses are also meant to be centralized at an 
European level, in order to avoid future dysfunctions concerning the transplant 
procedures; the mentioned aspect therefore constitutes one of the biggest positive 
steps attributed to the adoption of Directive 2010/45/EU at the EU’s level. Though 
Romania does not dispose, at the moment, of national records on undesired and 
unexpected occurrences associated with any stage of the chain from donation to 
transplantation that might lead to the transmission of a communicable disease, to 
death or life-threatening, disabling or incapacitating conditions for patients or 
which results in, or prolongs hospitalization or morbidity, it is expected that such 
data bases are created, as to collect relevant information on the unintended 
responses, including a communicable disease, in the living donor or in the recipient 
that might be associated with any stage of the chain from donation to 
transplantation that is fatal, life-threatening, disabling, incapacitating, or which 
results in, or prolongs donor’s or recipient’s hospitalization or has the potential of 
causing morbidity. These data are meant to be registered at a national and 
European level, in order to avoid future incidents or adverse medical responses and 
to provide consumers of medical services with high, uniform standards of safety. 
As mentioned above, the regular storage of such data is that of a 30 years period, 
imposed by the new European standards.  
Harmonizing the creation of national data bases on serious adverse events 
associated to organ transplants and the development of a common approach at the 
European Union’s level as to evaluating post-transplant results are to be welcomed, 
especially from the angle of the necessity of recording medical events in the state 
of recipients’ health, at regular intervals following transplantation. Such recording 
procedures may also help identify the extent to which re-transplantation becomes 
necessary for certain recipients, as well as examining post-transplant outcomes, 
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while focusing on national data bases of serious adverse events resulting from 
different categories of organ donation.  
 
5.3. The Principle of Benevolent Offering of Human Organs 
The benevolent character of organ offering represent no novelty of the commented 
European act, its roots being found in the immoral character of transactions over 
the human body, usually kept in most of the Member States’ legislations; though 
not newly proclaimed, the express reiteration of the organs sell prohibition is meant 
to eradicate all potential discrepancies between national legal provisions, some 
incomplete ore evasive, as to ensure a harmonized point of view at the EU’s level, 
on the immoral and illicit character of transactions over human organs intended for 
transplantation. Directive 2010/45/EU imposes Member States, in article 13, the 
duty to ensure that donations of organs from deceased and living donors are 
“voluntary and unpaid”. Paragraph 2 of the cited article mentions, however, 
donors’ right of compensation for expenses objectively related to the transplant 
procedure, establishing that “the principle of non-payment shall not prevent living 
donors from receiving compensation, provided it is strictly limited to making good 
the expenses and loss of income related to the donation; Member States shall 
define the conditions under which such compensation may be granted, while 
avoiding there being any financial incentives or benefit for a potential donor”1. 
Basically, what the Directive imposes in the area concerned is that all Member 
States ensure that the procurement of organs is carried out on a non-profit basis, 
perpetuating a legal state already existent in most of EU’s members, where the 
organs donations are already seen, at the level of relevant legislation, as excluding 
validity of offers to sell or purchase the human organs involved.  
The aspect of altruistically oriented behavior is essential in the field of human 
organs transplant, while, in the terms of Directive 2010/45/EU, the violation of 
these principles might be associated with risks that are normally unacceptable in 
the process of organ transplant. For instance, where organ donation is not 
voluntary, but imposed or is oriented towards financial gain, it is the quality of the 
process of donation that is put under question, while diminishing or evanishing 
recipient’s warranties of safety. Therefore, in hypotheses in which the donor’s 
                                                 
1Advertising for human organs also remains prohibited, as regulated by paragraph 3 of article 13 
(“Member States shall prohibit advertising the need for or availability of organs where such 




main scope lies not in benevolent purposes such as improving the quality of 
recipient’s life or saving the life of another person, the organ offer has the potential 
of endangering recipient’s health, no warranties attached to the sincere character of 
donor’s declarations on his or her medical record. The Preamble of Directive 
2010/45/EU recalls that, even in the cases in which the process of organ 
transplantation is developed in compliance with the appropriate quality standards, 
donor’s declarations or clinical history might not be sufficiently accurate in terms 
of health conditions or diseases potentially transmissible from donor to recipient, as 
long as these data are obtained from either a potential living donor or, for instance, 
from the relatives of a potential deceased donor who are pursuing financial gain or, 
in certain hypotheses, are subjected to some kind of coercion interfering with their 
decision on the organ donation. Therefore, the deliberately maintained silence over 
negative medical history could give rise to numerous safety problems for potential 
recipients, since the medical team would have a limited capability for performing 
an appropriate risk assessment1.  
As it has been observed, the promotion of altruism in organ donation at the EU’s 
level and the prohibition on financial gain associated to human organs donation are 
connected to broader bioethical principles and human rights, in the attempt of 
preserving human dignity and of avoiding the so-called instrumentalisation of 
human bodies, reminding the rule according to which no part of the human body 
may not be the subject of commercial transactions.  
Another feature worth noting is that at this point, Romania, as a Member State, is 
also called to provide efficient legal remedies, while adopting and implementing 
operating procedures for: (a) the verification of donor’s identity; (b) the 
verification of details of the donor's or the donor's family's consent, authorization 
or absence of any objection, in accordance with the other national rules that apply 
in the field of donation and procurement of human organs; (c) the verification of 
the completion of the organ and donor characterization in accordance with article 7 
and the annex of Directive 2010/45/EU; (d) the procurement, preservation, 
packaging and labeling of organs in accordance with articles 5, 6 and 8 of Directive 
                                                 
1
 In this context, The Charter of Fundamental Rights of the European Union should be recalled, 
notably the principle set out in article 3, paragraph (2), letter (c) thereof. The mentioned principle of 
non onerous organs procurement is also enshrined in article 21 of the Convention on Human Rights 
and Biomedicine of the Council of Europe, which many Member States have ratified and it is also 
reflected in the World Health Organization Guiding Principles on Human Cell, Tissue and Organ 
Transplantation, whereby the human body and its parts may not be the subject of commercial 
transactions.  
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2010/45/EU; (e) the transportation of organs in accordance with article 8 of 
Directive 2010/45/EU; (f) ensuring traceability of human organs, in accordance 
with article 10 of Directive 2010/45/EU, guaranteeing compliance with the 
European Union’s and national provisions on the protection of personal data and 
confidentiality; (g) the accurate, rapid and verifiable reporting of serious adverse 
events and reactions in accordance with article 11(1) of Directive 2010/45/EU; (h) 
the management of serious adverse events and reactions in accordance with Article 
11(2) of Directive 2010/45/EU. In addition, as recorded in article 5 of the 
mentioned Directive, the harmonized framework for quality and safety is meant to 
ensure that the healthcare personnel involved at all stages of the transplant chain, 
from donation to transplantation or organ disposal, are suitably trained and 
adequately competent, including the development of specific training programs for 
this medical personnel.  
 
6. Setting Uniform Standards for Confidentiality of Personal Data 
This part of the paper is concentrated on the necessity of elaboration, at a national 
level, of uniform security standards when processing of personal data of organ 
donors and recipients both by public hospitals and private clinics1. The text of 
article 16 of Directive 2010/45/EU is dedicated to the question of confidentiality 
and protection of personal data in the field of human organs transplants, Member 
States being called to ensure that the fundamental right to protection of personal 
data is fully and effectively protected in all organ donation and transplantation 
activities, in conformity with European Union’s provisions on the protection of 
personal data2. 
With respect to Directive 95/46/EC provisions on the protection of personal data, 
Romanian Public authorities are thus subjected to the duty of taking all necessary 
measures to ensure that the data processed relating to organ transplants are kept 
                                                 
1
 In order to meet the quality and safety requirements laid down in the Directive discussed, the 
medical team is requested to obtain all necessary information from living donors, purpose in which 
the medical team is subjected to a specific duty to inform the potential donors, providing them with 
the needed information, as to understand the consequences and the risks of donation. In the case of 
deceased donation, as mentioned above, the medical team, where possible and appropriate, is 
requested to obtain such information from relatives of the deceased donor; in accordance to article 7 
of the Directive, the medical team shall also endeavor to make all parties from whom information is 
requested aware of the importance of the swift transmission of that information.  
2
 Such as Directive 95/46/EC and, in particular, article 8, paragraph (3), articles 16 and 17, as well as 




confidential and secure as provided by articles 16 and 17 of Directive 95/46/EC 
and that any unauthorized accessing of data or systems that makes identification of 
donor or recipients possible is penalized in accordance with article 23 of Directive 
2010/45/EU. Thus any use of systems or data that makes the identification of 
donors or recipients possible oriented towards tracing donors or recipients, in cases 
other than those permitted by article 8, paragraph (2) and (3) of Directive 
95/46/EC, research pursuing medical purposes included, are penalized in 
accordance with article 23 of  Directive 2010/45/EU. Another important feature is 
that the processing of data concerning health is usually prohibited, a rule which has 
to be reshaped as to fit under the specific requests of the organs transplants 
procedure; article 8 of Directive 95/46/EC of the European Parliament and of the 
Council of 24 October 1995 on the protection of individuals with regard to the 
processing of personal data and on the free movement of such data prohibits in 
principle the processing of data concerning health, while laying down limited 
exemptions. Directive 95/46/EC also requires the controller to implement 
appropriate technical and organizational measures to protect personal data against 
accidental or unlawful destruction or accidental loss, alteration, unauthorized 
disclosure or access and against all other unlawful forms of processing. In the 
context of human organs transplantation, Member States are therefore called to 
ensure that strict confidentiality rules and security measures are in place for the 
protection of donors’ and recipients’ personal data, in accordance with Directive 
95/46/EC1. 
 
7. Intricacies of the Traceability of Organs  
As opposed to the actual state of progress, the traceability of organs transplant 
cases, at all stages of the chain, becomes vital under the terms of Directive 
2010/45/EU, as to permit competent authorities to access relevant data on organ 
and donor characterization during a minimal period of 30 years since the human 
organs procurement through a valid donation2. Most importantly, Member States 
                                                 
1
 As a general principle, the identity of the recipient(s) should not be disclosed to the donor or the 
donor’s family, except in cases in which the national legislation in force, under specific conditions, 
might allow such information to be made available to donors or donors’ families and organ recipients. 
It should be noted that the Romanian legislation in force does not establish particular cases of donors 
or donors’ families and organ recipients’ right to have access to personal data concerning health; 
however, this state of affairs is expected to change, at the moment of Directive 2010/45/EU 
transposition into national law. See, for further details (Simion, 2011, pp. 219-220). 
2
 In accordance to article 10 of the mentioned European act, Member States have the duty to ensure 
that “all organs procured, allocated and transplanted on their territory can be traced from the donor to 
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have to make sure in the future, on one hand, that the competent authority or other 
bodies involved in the chain from donation to transplantation or disposal keep the 
data needed to ensure traceability at all stages of the chain, from donation to 
transplantation or disposal and the information on organ and donor 
characterization, as specified in the annex, in accordance with the framework for 
quality and safety set by the Directive discussed and, on the other hand, that data 
required for full traceability is kept for a minimum of 30 years after donation1. In 
our opinion, founding a traceability of organs system will represent one of the most 
difficult tasks for the Romanian Health Department, as at the moment there is no 
tradition of using electronic data bases for the registration of living donors, 
potential recipients or severe reactions associated to human organ transplants.  
From the transport of human organs perspective, safety of transport is at the core of 
the medical procedure itself, as poor standards of transportation may irremediably 
endanger the quality of transported organs. Therefore, as requested by article 8 of 
Directive 2010/45/EU, Romanian authorities of resort are called to ensure that the 
organizations, bodies or companies involved in the transportation of organs have 
appropriate operating procedures in place to ensure the integrity of the organs 
during transport and a suitable transport time and that the labels of the shipping 
containers used for transporting organs contain information on the organ 
procurement organization and the establishment where the organ procurement took 
place, their addresses and telephone numbers included. Another set of data 
contained by the mentioned labels concern the identification of the transplantation 
centre of destination, its address and telephone number included. Finally, a 
statement that the package contains an human organ intended for transplantation, 
specifying the type of organ, accompanied by the expression “Handle with care” 
must be attached to the shipping containers used for transporting organs. 
Nevertheless, the containers will be accompanied by a list of recommended 
transport conditions and of instructions for keeping the container at an appropriate 
temperature and position. Also, in accordance to the new European standards, the 
organs transported have to be accompanied by a report on the organ and donor 
characterization, as underlined in the section above.  
                                                                                                                            
the recipient”, in order to ensure safety for the health of donors and recipients. Additionally, Member 
States are called to ensure the implementation of a donor and recipient identification system, able to 
identify every donation and the associated organs and recipients; to this respect, the Member States 
must ensure that confidentiality and data security measures comply with European Union’s and 
national provisions, as referred to in article 16 of Directive 2010/45/EU. 
1




It is interesting to observe that selection requirements for living organ donation 
include, in accordance with the new European standards, an assessment by 
qualified healthcare professionals regarding donor’s health and medical history, as 
well as a psychological evaluation of the donor, if necessary. Directive’s provisions 
also establish grounds for the exclusion of organ donation by living donors in 
hypotheses in which the organ donation may present serious health risks to 
potential recipients or to donors themselves particularly form the angle of 
transmitting diseases. Which is also worth noting is that no reference is made in the 
Directive text as to specific limits or exclusions of donors based on their spousal or 
genetic relationship to the potential organ recipient. Contemporary Romanian 
legislation makes no distinction on the mentioned criteria either; however, the 
future legal text transposing Directive 2010/45/EU into Romanian law may 
represent a good opportunity for the legislator to establish detailed rules concerning 
spousal or genetic relationship between the donor and the potential organ recipient 
 
8. Concluding Remarks 
The article focused on the technical and legislative difficulties brought on the 
Romanian Public healthcare system by the recent adoption on 7 July 2010, of 
Directive 2010/45/EU of the European Parliament and of the Council on standards 
of quality and safety of human organs intended for transplantation, which is 
expected to be transposed in the national law before 2013. As recorded by article 6 
of the Directive, organ procurement is to be subjected to uniform rules, Member 
States being called to ensure that medical activities regarding organ procurement, 
such as donor selection and evaluation, respect the advice and the guidance of a 
doctor of medicine, also ensuring that design, construction and maintenance of the 
operating locations, in which the organ procurement takes place, are compelled to 
adequate standards of quality and safety. In addition, it becomes compulsory for 
the Member States to ensure that the relevant European Union’s legislation, 
international and national legislation, standards and guidelines on the sterilization 
of medical devices are respected while performing activities related to organ 
procurement material and equipment. The exchange of organs between Member 
States establishments is an important way of increasing the number of organs 
available for the European patients and of ensuring a better match between donor 
and recipient, therefore improving the quality of the transplantation. This feature is 
particularly important for the optimum treatment of specific patients, such as 
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patients requiring urgent treatment, hypersensitive patients or pediatric patients, 
cases in which available organs should be able to cross borders without 
unnecessary problems and delays. However, in practice, transplantation is carried 
out by hospitals or professionals falling under different jurisdictions and there are 
significant differences in quality and safety requirements between Member States, 
an aspect that fully justifies the adoption of uniform safety standards.   
Concerning the Administrative procedures to be changed, we attempted to 
underline the importance of creating a specialized Administrative body, uncharged 
with the accurate, rapid and verifiable reporting (to the European organisms 
inclusively) of serious adverse events and reactions related to human organs 
transplants, as well as that of creating national and local Administrative organs in 
charge of the management of serious adverse events and reactions in accordance 
with Directive 2010/45/EU provisions. As to the elaboration of new legislation on 
packaging and labeling of organs in accordance with the new European standards, 
the elaboration of legal rules and specific Administrative procedures for the 
authorization of transplantation centers or the establishment of conditions of 
procurement and systems of traceability of organs intended for transplantation into 
the human body, all these represent major themes for the Public Health Department 
in the next two years, since the recent experience of semi-failure in the field of 
healthcare reforms showed the lesson of the importance of details when public 
health is concerned.  
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